|
Tourette syndrome - Pipeline Review, H1 2019 |
Jan 31 2019 |
72 |
Global |
$2,000.00 |
|
|
Otitis Media - Pipeline Review, H1 2019 |
Jan 31 2019 |
60 |
Global |
$2,000.00 |
|
|
Lyme Disease - Pipeline Review, H1 2019 |
Jan 31 2019 |
46 |
Global |
$2,000.00 |
|
|
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2019 |
Jan 31 2019 |
44 |
Global |
$2,000.00 |
|
|
Hidradenitis Suppurativa - Pipeline Review, H1 2019 |
Jan 31 2019 |
157 |
Global |
$2,000.00 |
|
|
Typhoid Fever - Pipeline Review, H1 2019 |
Jan 31 2019 |
51 |
Global |
$2,000.00 |
|
|
Left Ventricular Dysfunction - Pipeline Review, H1 2019 |
Jan 31 2019 |
44 |
Global |
$2,000.00 |
|
|
Secondary Hyperparathyroidism - Pipeline Review, H1 2019 |
Jan 31 2019 |
58 |
Global |
$2,000.00 |
|
|
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2019 |
Jan 31 2019 |
35 |
Global |
$2,000.00 |
|
|
Hypotension - Pipeline Review, H1 2019 |
Jan 31 2019 |
50 |
Global |
$2,000.00 |
|
|
Nocturia - Pipeline Review, H1 2019 |
Jan 31 2019 |
46 |
Global |
$2,000.00 |
|
|
Primary Biliary Cirrhosis - Pipeline Review, H1 2019 |
Jan 31 2019 |
128 |
Global |
$2,000.00 |
|
|
House Dust Mite Allergy - Pipeline Review, H1 2019 |
Jan 31 2019 |
51 |
Global |
$2,000.00 |
|
|
Sedation - Pipeline Review, H1 2019 |
Jan 31 2019 |
52 |
Global |
$2,000.00 |
|
|
Degenerative Disc Disease - Pipeline Review, H1 2019 |
Jan 31 2019 |
65 |
Global |
$2,000.00 |
|
|
Hyperalgesia - Pipeline Review, H1 2019 |
Jan 31 2019 |
38 |
Global |
$2,000.00 |
|
|
Cervical Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
1026 |
Global |
$2,000.00 |
|
|
Colorectal Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2548 |
Global |
$2,500.00 |
|
|
Pancreatic Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2787 |
Global |
$2,500.00 |
|
|
Melanoma - Pipeline Review, H2 2018 |
Dec 21 2018 |
2285 |
Global |
$2,500.00 |
|
|
Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lipodystrophy Syndrome (LS)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Cutaneous Squamous Cell Carcinoma (cSCC) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
157 |
Global |
$6,250.00 |
|
|
Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lyme disease (LD)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
163 |
Global |
$6,250.00 |
|
|
Limb Girdle Muscular Dystrophy (LGMD)-Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Charcot Marie Tooth (CMT) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
